Does paraoxonase play a role in susceptibility to cardiovascular disease? (Q33720558)

28 July 2017

1 reference

title

Does paraoxonase play a role in susceptibility to cardiovascular disease? (English)

1 reference

28 July 2017

1 reference

Aviram M

1

1 reference

28 July 2017

publication date

1 September 1999

1 reference

Trends in Molecular Medicine

28 July 2017

published in

1 reference

28 July 2017

volume

5

1 reference

28 July 2017

issue

9

1 reference

28 July 2017

page(s)

381-386

1 reference

Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

LDL oxidation by arterial wall macrophages depends on the oxidative status in the lipoprotein and in the cells: role of prooxidants vs. antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Increased uptake of LDL by oxidized macrophages is the result of an initial enhanced LDL receptor activity and of a further progressive oxidation of LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Receptor-mediated transport of cholesterol between cultured cells and high-density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Structural and functional diversity of paraoxonases

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase-gene polymorphisms associated with coronary heart disease: support for the oxidative damage hypothesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Increased immunolocalization of paraoxonase, clusterin, and apolipoprotein A-I in the human artery wall with the progression of atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Genetic-dietary regulation of serum paraoxonase expression and its role in atherogenesis in a mouse model

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Mice lacking serum paraoxonase are susceptible to organophosphate toxicity and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

A 192Arg variant of the human paraoxonase (HUMPONA) gene polymorphism is associated with an increased risk for coronary artery disease in the Japanese

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase gene polymorphism and coronary artery disease in Indian subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Genetic polymorphism of paraoxonase and the risk of coronary heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Gln-Arg192 polymorphism of paraoxonase and coronary heart disease in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase polymorphism (Gln192-Arg) is associated with coronary heart disease in Japanese noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The Gln-Arg 191 polymorphism of the human paraoxonase gene is not associated with the risk of coronary artery disease among Chinese in Taiwan.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Lack of association between carotid intima-media thickness and paraoxonase gene polymorphism in non-insulin dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The Gln-Arg191 polymorphism of the human paraoxonase gene (HUMPONA) is not associated with the risk of coronary artery disease in Finns

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The gln-Arg192 polymorphism of human paraoxonase gene is not associated with coronary artery disease in italian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The paraoxonase Gln-Arg 192 polymorphism in subjects with ischaemic heart disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The Gln/Arg polymorphism of human paraoxonase (PON 192) is not related to myocardial infarction in the ECTIM Study

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase polymorphism Met-Leu54 is associated with modified serum concentrations of the enzyme. A possible link between the paraoxonase gene and increased risk of cardiovascular disease in diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The codon 55 polymorphism in the paraoxonase 1 gene is not associated with the risk of coronary heart disease in Asian Indians and Chinese

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase-2 gene (PON2) G148 variant associated with elevated fasting plasma glucose in noninsulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS1357-4310%2899%2901546-4

7 January 2021

10.1016/S1357-4310(99)01546-4

Identifiers

DOI

1 reference

28 July 2017

1 reference